newsfilter
← Latest News
PR Newswire·

Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending

Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment...